Literature DB >> 32691450

Deciphering human γδ T cell response in cancer: Lessons from tumor-infiltrating γδ T cells.

Elena Lo Presti1,2, Francesco Dieli1,2, Jean Jacques Fourniè3,4,5,6,7, Serena Meraviglia1,2.   

Abstract

The finding that γδ T cells are present among tumor-infiltrating lymphocytes in humans suggests they participate in tumor immune surveillance, but their relevance is unclear because the relative abundance of tumor-infiltrating γδ T cells correlates with positive or negative, or even do not correlate with prognosis. This likely depends on the fact that tumor-infiltrating γδ T cells may play substantially different effector or regulatory functions, and correlation with patient's prognosis relies on distinct γδ T cell subsets in the context of the tumor. There is interest to exploit γδ T cells in tumor immunotherapy, but to make this approach successful there is urgent need to fully understand the biological functions of γδ T cells and of how they can be manipulated in vivo and ex vivo to safely provide benefit to the host. This review focuses on our previous and ongoing studies of tumor-infiltrating γδ T lymphocytes in different types of human cancer. Moreover, we discuss the interaction of tumor-infiltrating γδ T cells with other cells and molecules present in the tumor microenvironment, and their clinical relevance on the ground, that deep knowledge in this field can be used further for better immunotherapeutic intervention in cancer.
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  clinical correlation; colon cancer; tumor microenvironment; tumor-infiltrating lymphocytes; γδ T lymphocytes

Year:  2020        PMID: 32691450     DOI: 10.1111/imr.12904

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  8 in total

Review 1.  The subtle interplay between gamma delta T lymphocytes and dendritic cells: is there a role for a therapeutic cancer vaccine in the era of combinatorial strategies?

Authors:  Domenico Galati; Serena Zanotta; Marialuisa Bocchino; Rosaria De Filippi; Antonio Pinto
Journal:  Cancer Immunol Immunother       Date:  2021-01-01       Impact factor: 6.968

Review 2.  Harnessing Unconventional T Cells and Innate Lymphoid Cells to Prevent and Treat Hematological Malignancies: Prospects for New Immunotherapy.

Authors:  Alessandro Allegra; Marco Casciaro; Elena Lo Presti; Caterina Musolino; Sebastiano Gangemi
Journal:  Biomolecules       Date:  2022-05-27

Review 3.  Cross-Talk between Oxidative Stress and m6A RNA Methylation in Cancer.

Authors:  Baishuang Yang; Qiong Chen
Journal:  Oxid Med Cell Longev       Date:  2021-08-24       Impact factor: 6.543

Review 4.  Comprehensive Analysis of the ILCs and Unconventional T Cells in Virus Infection: Profiling and Dynamics Associated with COVID-19 Disease for a Future Monitoring System and Therapeutic Opportunities.

Authors:  Elena Lo Presti; Andrea De Gaetano; Giovanni Pioggia; Sebastiano Gangemi
Journal:  Cells       Date:  2022-02-04       Impact factor: 6.600

5.  A Mathematical Model of In Vitro Cellular Uptake of Zoledronic Acid and Isopentenyl Pyrophosphate Accumulation.

Authors:  Elena Lo Presti; Laura D'Orsi; Andrea De Gaetano
Journal:  Pharmaceutics       Date:  2022-06-14       Impact factor: 6.525

6.  Vδ2 T cells are associated with favorable clinical outcomes in patients with bladder cancer and their tumor reactivity can be boosted by BCG and zoledronate treatments.

Authors:  Sylvain Nguyen; Mathieu F Chevalier; Sulayman Benmerzoug; Valérie Cesson; Anna K Schneider; Sonia-Cristina Rodrigues-Dias; Florence Dartiguenave; Ilaria Lucca; Patrice Jichlinski; Beat Roth; Denise Nardelli-Haefliger; Laurent Derré
Journal:  J Immunother Cancer       Date:  2022-08       Impact factor: 12.469

7.  A Novel Immune-Related Seventeen-Gene Signature for Predicting Early Stage Lung Squamous Cell Carcinoma Prognosis.

Authors:  Tao Fan; Zhiliang Lu; Yu Liu; Liyu Wang; He Tian; Yujia Zheng; Bo Zheng; Liyan Xue; Fengwei Tan; Qi Xue; Shugeng Gao; Chunxiang Li; Jie He
Journal:  Front Immunol       Date:  2021-06-11       Impact factor: 7.561

8.  Blocking of EphA2 on Endometrial Tumor Cells Reduces Susceptibility to Vδ1 Gamma-Delta T-Cell-Mediated Killing.

Authors:  Robert Hudecek; Barbora Kohlova; Ingrid Siskova; Martin Piskacek; Andrea Knight
Journal:  Front Immunol       Date:  2021-10-07       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.